July 6, 2022
In an effort to provide psychiatric patients with the best possible treatment, Reem Hospital officially introduced its Esketamine Clinic, where an expert team of consulting psychiatrists briefed psychiatrists from across the GCC on the pros and cons of the drug esketamine, which is administered to patients with treatment-resistant depression. The clinic will offer the first FDA-approved fast-acting therapy for treatment-resistant depression (TRD). This is a new achievement and a hopeful step in the right direction for many adults who struggle with depression and have not responded adequately to at least two different antidepressants
Patient Login
